British Columbia Cancer Agency-医療機器分野:企業M&A・提携分析

◆英語タイトル:British Columbia Cancer Agency - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011505
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy, chemotherapy services, nursing care, patient and family counseling, nutrition counseling, pharmacy services, pain and symptom control service, teaching and applied research activities and cancer information library. Its cancer care program includes prevention, screening and early detection, diagnosis and treatment services, support programs, community programs, research and education. BC Cancer Agency partners with communities to provide a network of chemotherapy clinics. It operates through its various centers across Canada. BC Cancer Agency is headquartered in Vancouver, British Columbia, Canada.

British Columbia Cancer Agency – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
British Columbia Cancer Agency, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
British Columbia Cancer Agency, Medical Equipment Deals By Type, 2011 to YTD 2017 6
British Columbia Cancer Agency, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
British Columbia Cancer Agency, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
British Columbia Cancer Agency, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
British Columbia Cancer Agency, Medical Equipment, Deal Details 10
Partnerships 10
Qiagen Enters Into Option For Licensing Agreement With BC Cancer For EZH2 Y641 Mutation Biomarker 10
Verisante Enters Into Licensing Agreement With British Columbia Cancer Agency 11
LED Medical Diagnostics To Enter Into Agreement With BC Cancer Agency And Genome BC To Develop Oral Cancer Risk-Assessment Test 12
Verisante Technology Enters Into Agreement With BC Cancer Agency And Fujian Normal University 13
Coastal Genomics Enters Into Licensing Agreement With BC Cancer Agency For Liquid Handling Automation Technology 14
British Columbia Cancer Agency – Key Competitors 15
British Columbia Cancer Agency – Key Employees 16
British Columbia Cancer Agency – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
British Columbia Cancer Agency, Medical Equipment, Key Facts 2
British Columbia Cancer Agency, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
British Columbia Cancer Agency, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
British Columbia Cancer Agency, Medical Equipment Deals By Type, 2011 to YTD 2017 6
British Columbia Cancer Agency, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
British Columbia Cancer Agency, Deals By Market, 2011 to YTD 2017 8
British Columbia Cancer Agency, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Qiagen Enters Into Option For Licensing Agreement With BC Cancer For EZH2 Y641 Mutation Biomarker 10
Verisante Enters Into Licensing Agreement With British Columbia Cancer Agency 11
LED Medical Diagnostics To Enter Into Agreement With BC Cancer Agency And Genome BC To Develop Oral Cancer Risk-Assessment Test 12
Verisante Technology Enters Into Agreement With BC Cancer Agency And Fujian Normal University 13
Coastal Genomics Enters Into Licensing Agreement With BC Cancer Agency For Liquid Handling Automation Technology 14
British Columbia Cancer Agency, Key Competitors 15
British Columbia Cancer Agency, Key Employees 16
British Columbia Cancer Agency, Other Locations 17

★海外企業調査レポート[British Columbia Cancer Agency-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Portland General Electric Co (POR)-エネルギー分野:企業M&A・提携分析
    Summary Portland General Electric Company (PGE) is a vertically integrated electric utility which generates, transmits, distributes, and retails electricity. The company generates electricity from wholly and jointly owned wind, natural gas, coal and hydroelectric plants. PGE also participates in the …
  • Novo Nordisk AS (NOVO B):企業の財務・戦略的SWOT分析
    Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • C. Uyemura & Co., Ltd. (4966):企業の財務・戦略的SWOT分析
    C. Uyemura & Co., Ltd. (4966) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Seven & i Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Central National-Gottesman Inc.:企業の戦略・SWOT・財務情報
    Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report Summary Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Engie SA (ENGI)-エネルギー分野:企業M&A・提携分析
    Summary Engie S.A. (Engie), formerly GDF Suez S.A., is an electric utility, which generates and distributes electricity and natural gas. It generates electricity using various sources including hydro, wind, solar, biomass, geothermal, nuclear, coal and fuel oil. The company supplies, distributes, tr …
  • Tohoku Electric Power Co Inc (9506):企業の財務・戦略的SWOT分析
    Tohoku Electric Power Co Inc (9506) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PT. Indonesia Power:企業の戦略的SWOT分析
    PT. Indonesia Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • 3D Systems Corporation:戦略・SWOT・企業財務分析
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fabric Development Inc:企業の戦略的SWOT分析
    Fabric Development Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • TAG Oil Ltd (TAO):石油・ガス:M&Aディール及び事業提携情報
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas company that explores, develops and produces natural gas and crude oil across Canada. The company owns and operates oil and gas properties in Taranaki Basin and East Coast Basin. It undertakes oil and gas projects such as Boar Hill Frontier, Waitangi H …
  • EnPro Industries Inc (NPO):企業の財務・戦略的SWOT分析
    Summary EnPro Industries Inc (EnPro) is a diversified company that offers engineering solutions. The company designs, develops, manufactures and markets proprietary engineered industrial products. It provides commercial vehicle wheel-end components. EnPro offers sealing solutions for a wide range of …
  • EOS imaging SA (EOSI):医療機器:M&Aディール及び事業提携情報
    Summary EOS imaging SA (EOS Imaging) is an orthopedic imaging company that designs, develops, and markets EOS patented medical imaging system. EOS captures whole body images of a standing patient in a single scan without any stitching or vertical distortion. Through EOS, the company provides the ful …
  • Wood Group Mustang Inc-石油・ガス分野:企業M&A・提携分析
    Summary Wood Group Mustang, Inc. (Wood Group Mustang), a subsidiary of John Wood Group PLC is an engineering management company. It provides engineering, procurement, and construction management (EPC) services to clients across diverse end markets. The company’s service portfolio comprises design an …
  • National Institute on Drug Abuse:製薬・医療:M&Aディール及び事業提携情報
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Fibria Celulose S.A.:企業の戦略・SWOT・財務情報
    Fibria Celulose S.A. - Strategy, SWOT and Corporate Finance Report Summary Fibria Celulose S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fortis Healthcare Ltd (FORTIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortis Healthcare Ltd (Fortis) is an integrated healthcare provider that delivers healthcare services in the Pan Asia-Pacific region. The company’s services portfolio comprises diagnostics, primary care, day care and specialty hospitals. It owns, operates, and manages a chain of multi-specia …
  • Shri Lakshmi Cotsyn Ltd.:企業の戦略・SWOT・財務情報
    Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆